218 related articles for article (PubMed ID: 21244355)
1. Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer's disease.
Longenberger J; Shah ZA
Curr Alzheimer Res; 2011 Jun; 8(4):434-42. PubMed ID: 21244355
[TBL] [Abstract][Full Text] [Related]
2. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
Höglund K; Blennow K
CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
[TBL] [Abstract][Full Text] [Related]
3. Statins: drugs for Alzheimer's disease?
Eckert GP; Wood WG; Müller WE
J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
[TBL] [Abstract][Full Text] [Related]
4. Can statins put the brakes on Alzheimer's disease?
Whitfield JF
Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
[TBL] [Abstract][Full Text] [Related]
5. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.
Riekse RG; Li G; Petrie EC; Leverenz JB; Vavrek D; Vuletic S; Albers JJ; Montine TJ; Lee VM; Lee M; Seubert P; Galasko D; Schellenberg GD; Hazzard WR; Peskind ER
J Alzheimers Dis; 2006 Dec; 10(4):399-406. PubMed ID: 17183151
[TBL] [Abstract][Full Text] [Related]
6. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
Höglund K; Syversen S; Lewczuk P; Wallin A; Wiltfang J; Blennow K
Exp Brain Res; 2005 Jul; 164(2):205-14. PubMed ID: 15937702
[TBL] [Abstract][Full Text] [Related]
7. Statin-like drugs for the treatment of brain cholesterol loss in Alzheimer's disease.
Biondi E
Curr Drug Saf; 2007 Sep; 2(3):173-6. PubMed ID: 18690964
[TBL] [Abstract][Full Text] [Related]
8. Statins and cognitive decline in patients with Alzheimer's and mixed dementia: a longitudinal registry-based cohort study.
Petek B; Häbel H; Xu H; Villa-Lopez M; Kalar I; Hoang MT; Maioli S; Pereira JB; Mostafaei S; Winblad B; Gregoric Kramberger M; Eriksdotter M; Garcia-Ptacek S
Alzheimers Res Ther; 2023 Dec; 15(1):220. PubMed ID: 38115091
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol and Alzheimer's disease: is there a link?
Simons M; Keller P; Dichgans J; Schulz JB
Neurology; 2001 Sep; 57(6):1089-93. PubMed ID: 11571339
[TBL] [Abstract][Full Text] [Related]
10. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
Höglund K; Wallin A; Blennow K
Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916
[TBL] [Abstract][Full Text] [Related]
11. Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD).
Lukiw WJ
Expert Opin Emerg Drugs; 2008 Jun; 13(2):255-71. PubMed ID: 18537520
[TBL] [Abstract][Full Text] [Related]
12. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
Sparks DL; Martin TA; Gross DR; Hunsaker JC
Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
[TBL] [Abstract][Full Text] [Related]
13. Statins for the treatment of dementia.
McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol and the biology of Alzheimer's disease.
Wolozin B
Neuron; 2004 Jan; 41(1):7-10. PubMed ID: 14715130
[TBL] [Abstract][Full Text] [Related]
16. Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Papadopoulos P; Tong XK; Hamel E
Neurobiol Aging; 2014 Jan; 35(1):203-12. PubMed ID: 23954171
[TBL] [Abstract][Full Text] [Related]
17. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
18. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
19. Disease-modifying therapies in Alzheimer's disease: how far have we come?
Hüll M; Berger M; Heneka M
Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.
Buxbaum JD; Cullen EI; Friedhoff LT
Front Biosci; 2002 Apr; 7():a50-9. PubMed ID: 11900994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
